NM_181351.5:c.1825+4754T>G

Variant names:

• chr11-113239918-T-G
• rs675646
• NM_181351.5:c.1825+4754T>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_181351.5(NCAM1):​c.1825+4754T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.071 in 152,236 control chromosomes in the GnomAD database, including 509 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.071 (509 hom., cov: 31)
• Consequence: NCAM1 NM_181351.5 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 0.700
• Publications: 1 publications found

Genes affected

NCAM1 (HGNC:7656): (neural cell adhesion molecule 1) This gene encodes a cell adhesion protein which is a member of the immunoglobulin superfamily. The encoded protein is involved in cell-to-cell interactions as well as cell-matrix interactions during development and differentiation. The encoded protein plays a role in the development of the nervous system by regulating neurogenesis, neurite outgrowth, and cell migration. This protein is also involved in the expansion of T lymphocytes, B lymphocytes and natural killer (NK) cells which play an important role in immune surveillance. This protein plays a role in signal transduction by interacting with fibroblast growth factor receptors, N-cadherin and other components of the extracellular matrix and by triggering signalling cascades involving FYN-focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3K). One prominent isoform of this gene, cell surface molecule CD56, plays a role in several myeloproliferative disorders such as acute myeloid leukemia and differential expression of this gene is associated with differential disease progression. For example, increased expression of CD56 is correlated with lower survival in acute myeloid leukemia patients whereas increased severity of COVID-19 is correlated with decreased abundance of CD56-expressing NK cells in peripheral blood. Alternative splicing results in multiple transcript variants encoding distinct protein isoforms. [provided by RefSeq, Aug 2020]

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.82).
• BA1: GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.151 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_181351.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	NCAM1	NM_181351.5	MANE Select	c.1825+4754T>G		intron	N/A	NP_851996.2	P13591-2
	NCAM1	NM_001400624.1		c.1825+4754T>G		intron	N/A	NP_001387553.1
	NCAM1	NM_001400620.1		c.1810+3603T>G		intron	N/A	NP_001387549.1

Ensembl Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	NCAM1	ENST00000316851.12	TSL:5 MANE Select	c.1825+4754T>G		intron	N/A	ENSP00000318472.8	P13591-2
	NCAM1	ENST00000533073.5	TSL:1	c.322+4754T>G		intron	N/A	ENSP00000486406.1	A0A0D9SF98
	NCAM1	ENST00000619839.4	TSL:5	c.1903+4754T>G		intron	N/A	ENSP00000480132.1	A0A087WWD4

Frequencies

GnomAD3 genomes AF: 0.0710 AC: 10796 AN: 152118 Hom.: 511 Cov.: 31

Gnomad AFR AF: 0.117

Gnomad AMI AF: 0.0307

Gnomad AMR AF: 0.0500

Gnomad ASJ AF: 0.0439

Gnomad EAS AF: 0.160

Gnomad SAS AF: 0.0369

Gnomad FIN AF: 0.0170

Gnomad MID AF: 0.0791

Gnomad NFE AF: 0.0537

Gnomad OTH AF: 0.0664

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.0710 AC: 10803 AN: 152236 Hom.: 509 Cov.: 31 AF XY: 0.0687 AC XY: 5111 AN XY: 74442

African (AFR) AF: 0.117 AC: 4854 AN: 41522

American (AMR) AF: 0.0501 AC: 766 AN: 15300

Ashkenazi Jewish (ASJ) AF: 0.0439 AC: 152 AN: 3466

East Asian (EAS) AF: 0.160 AC: 829 AN: 5176

South Asian (SAS) AF: 0.0365 AC: 176 AN: 4816

European-Finnish (FIN) AF: 0.0170 AC: 180 AN: 10618

Middle Eastern (MID) AF: 0.0782 AC: 23 AN: 294

European-Non Finnish (NFE) AF: 0.0537 AC: 3655 AN: 68016

Other (OTH) AF: 0.0662 AC: 140 AN: 2116

Alfa AF: 0.0671 Hom.: 524

Bravo AF: 0.0766

Asia WGS AF: 0.0710 AC: 246 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.82
CADD	Benign	11
DANN	Benign	0.74
PhyloP100		0.70
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs675646; hg19: chr11-113110640;